Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
04/2007
04/25/2007CN1951922A Lappaconitine hydrobromide preparation method
04/25/2007CN1951921A Method for preparing kukoline hydrochloride single-crystal using acid and alkaline method
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/25/2007CN1312155C Method for separating and purifying 9-nitro camptothecin
04/25/2007CN1311988C Imide compounds and optical recording media made by using the same
04/24/2007CA2171934C Endothelin receptor antagonists
04/24/2007CA2131644C Quinoline compounds
04/19/2007WO2007044475A1 Process for the synthesis of compounds for selectin inhibition
04/19/2007US20070088037 Cancer and fibrotic diseases
04/19/2007CA2624552A1 Process for the synthesis of compounds for selectin inhibition
04/18/2007EP1353673B1 Camptothecin derivatives
04/18/2007CN1950341A Naphthalimide derivatives for the treatment of cancer
04/18/2007CN1948308A Intermediate compound for synthesizing lamel larin H and its derivatives and synthesizing method
04/18/2007CN1948291A 1-substituted amine methyl diversine derivative and its preparation method
04/18/2007CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives
04/18/2007CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors
04/17/2007US7205311 Therapeutic acridone and acridine compounds
04/17/2007US7205300 Aryl fused azapolycyclic compounds
04/12/2007WO2007039884A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists
04/12/2007US20070082923 Process for the synthesis of compounds for selectin inhibition
04/12/2007US20070082922 Huperzine a prodrugs and uses thereof
04/11/2007EP1772457A2 Preparation of levofloxacin and forms thereof
04/11/2007EP1499595B1 Amonafide salts
04/11/2007EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
04/11/2007CN1944431A 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative
04/11/2007CN1309385C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
04/10/2007US7202361 Antitumoral ecteinascidin derivatives
04/10/2007CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
04/05/2007WO2007038459A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007WO2006116311A3 Opioid receptor agonist compounds and their use in treatment of pain
04/05/2007WO2006101859A3 Piperidinyl substituted cyclohexane-1,4-diamines
04/05/2007WO2006056443A3 Method for solid-phase peptide synthesis and purification
04/05/2007US20070078137 Method of inhibiting neurotrophin-receptor binding
04/05/2007CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/04/2007EP1768667A1 Cannabinoid receptor ligands
04/04/2007CN1942187A 17 beta-acetamide-4-azasteroids as androgen receptor modulators
04/04/2007CN1939918A Production of midanping
04/04/2007CN1939915A 喹啉衍生物 Quinoline derivatives
04/04/2007CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
04/04/2007CN1308312C Huperzine B bimolecular and double function group devicative, preparing method and its use
04/04/2007CN1308311C Novel pyridine- and quinoline-derivatives
03/2007
03/29/2007WO2007014137A3 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
03/29/2007US20070072893 Substituted imidazo ring systems and methods
03/29/2007US20070072892 [3H]-(S,S)-2,2-dimethyl-5-(6-phenyl-pyridazin-3-yl)-5-aza-2-azonia-bicyclo[2.2.1]heptane, iodide; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, mild cognitive impairment, age-associated memory impairment
03/28/2007EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage
03/28/2007EP1765819A1 Azaindoles useful as inhibitors of protein kinases
03/28/2007EP1765784A2 Antibiotic cycloalkyltetrahydroquinoline derivatives
03/28/2007EP1765777A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
03/28/2007EP1765770A1 Process for the preparation of gabapentin
03/28/2007EP1138745B1 Organic electroluminescent element
03/28/2007CN1938320A Compounds and methods for treating dyslipidemia
03/28/2007CN1938304A Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
03/28/2007CN1938275A Novel thio containing hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
03/28/2007CN1938244A Fluoridation method
03/28/2007CN1307176C Novel alkoxypyridine-derivatives
03/27/2007US7196195 8-chloro-6,11-dihydro-11-(4-piperidilydene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine); good solubility; anti-allergen
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/22/2007WO2007030940A2 Methods of modulating neurotrophin-mediated activity
03/22/2007WO2007030939A2 Methods of modulating neurotrophin-mediated activity
03/22/2007US20070066827 Process for the preparation of aryl fused polycyclic lactams
03/22/2007CA2622571A1 Methods of modulating neurotrophin-mediated activity
03/21/2007CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes
03/21/2007CN1933808A Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof
03/21/2007CN1305873C [18F] Fluorin marked pyridine compound and method for preparing the same and uses as dopamine D4 receptor developer
03/20/2007US7193085 Use in a printing ink suitable for the ink jet
03/20/2007US7192977 Duocamycin prodrugs; binding to Dna
03/20/2007CA2157147C An improved process for the preparation of n-oxyl hindered amine esters
03/15/2007WO2007028638A1 Fused and spirocycle compounds and the use thereof
03/15/2007WO2007028337A1 Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds
03/15/2007US20070060757 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
03/14/2007EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/14/2007EP1465629B1 5-ht3 receptor antagonists and methods of use
03/14/2007EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
03/14/2007EP1019388B1 Preparation of perylene-3,4-dicarboxylic anhydrides
03/14/2007EP0989978B1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
03/14/2007CN1930171A 7H-8,9-dihydro-pyrano(2,3-C)imidazo(1,2A)pyridine derivatives and their use as gastric acid secretion inhibitors
03/14/2007CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
03/14/2007CN1927866A Preparation method of methyl thienotetrahydropyridinacetate
03/14/2007CN1927864A Preparation method of thienotetrahydropyridinacetic acid and salt thereof
03/14/2007CN1927863A Preparation method of thienotetrahydropyridinacetic acid and salt thereof
03/14/2007CN1304395C New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
03/14/2007CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
03/13/2007US7189852 Preparing renzapride (hydrochloride) on a laboratory or industrial scale by a simplified process of forming the acyl chloride derivative of 2-(methoxy),3-acyamino,5-chlorobenzoic acid by reacting oxalyl or thionyl chloride in a solvent, e.g. dimethylformamide; coupling with 1-diazabicylo(3.3.1)nonane
03/13/2007US7189383 Compounds with halogen for diagnosis with ethers or sulfides for cancer
03/08/2007WO2007027719A2 Lisofylline analogues and their pharmeacuetical uses
03/08/2007WO2007025534A1 Fredericamycin derivatives
03/08/2007US20070054933 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/08/2007DE102005041760A1 New fredericamycin A derivatives with carbon-bonded B-ring substituent, are well tolerated topoisomerase I and/or II inhibitors especially useful for treating cancers or tumors
03/08/2007CA2618970A1 Lisofylline analogs and methods for use
03/07/2007EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/07/2007EP1758908A1 Extraction of alkaloids from opium
03/07/2007EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
03/07/2007EP1758866A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
03/07/2007EP1758865A1 Pyridine analogs as c5a antagonists
03/07/2007EP1758847A1 Inhibitors of histone deacetylase
03/07/2007EP1758655A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders
03/07/2007EP1685131B1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
03/07/2007EP1029016B1 Novel chemiluminescent labeling compounds
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926113A Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 110